Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2020Bioscience ReportsOpen Access

NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis

View Full Paper
Ask AI
Bookmark
Share

Authors

QHQiang HuangFujian Medical UniversitySXShijiang XingAPAiping Peng

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Huang et al. (2020) studied this question.

synapsesocial.com/papers/6a9bd6fd0b0288a0688ff1fdhttps://doi.org/10.1042/bsr20193489
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1lncRNA NORAD Contributes to Colorectal Cancer Progression by Inhibition of miR-202-5p2018 · 107 citations
  2. 2Identification of potential cancer-related pseudogenes in lung adenocarcinoma based on ceRNA hypothesis2017 · 28 citations
  3. 3Global cancer statistics, 20122015 · 27,468 citations
  4. 4Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis2007 · 614 citations
  5. 5TMEM2 Is a SOX4-Regulated Gene That Mediates Metastatic Migration and Invasion in Breast Cancer2016 · 76 citations